Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.9 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.02 | 0.9 |